NCT05717387

Brief Summary

Prediabetes is a high-risk state for diabetes development, lifestyle modification is the cornerstone of diabetes prevention. Two novel types of intermittent fasting recently have received more attention: the 5:2 diet and time-restricted eating (TRE). TRE requires individuals to eat in a specified number of hours per day (typically 4 to 10 hours) without energy intake restriction. The 5:2 diet involves 5 feast days and 2 fast days per week; participants eat ad libitum without restriction on feast days while 25% of energy needs (approximately 500-800 kcal per day) are consumed on fast day. This randomized controlled trial aimed to evaluate the effect of TRE and the 5:2 diet on glucose homeostasis and cardiometabolic risk factors in prediabetes over 6 months compared to usual health care.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
87

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 28, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

February 8, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

April 11, 2023

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

November 9, 2023

Status Verified

November 1, 2023

Enrollment Period

1.3 years

First QC Date

January 28, 2023

Last Update Submit

November 8, 2023

Conditions

Keywords

TREThe 5:2 dietGlucose Homeostasisprediabetesobesity

Outcome Measures

Primary Outcomes (1)

  • Change in percent of time in range (glucose between 3.9-7.8mmol/L) over 6 months measured with continuous glucose monitoring.

    Baseline to months 6

Secondary Outcomes (21)

  • Change in mean glucose levels

    Baseline and months 6

  • Change in glycemic variability

    Baseline and months 6

  • Change in percent of time below range

    Baseline and months 6

  • Change in percent of time above range

    Baseline and months 6

  • Change in resting metabolic rate

    Baseline and months 6

  • +16 more secondary outcomes

Study Arms (3)

Time-restricted eating

EXPERIMENTAL

Participants in the TRE group will be instructed to eat during a window of 8 h/d (8 am to 4 pm)

Behavioral: Time-restricted eating

the 5:2 diet

EXPERIMENTAL

Participants in the 5:2 diet group will be instructed to consume 500-600 kcal/d on fast days and eat ad libitum on feast days.

Behavioral: The 5:2 diet

Control

NO INTERVENTION

Participants in the control group will receive a general lifestyle counseling.

Interventions

Participants in the TRE group will be instructed to eat during a window of 8 h/d (8 am to 4 pm).

Time-restricted eating
The 5:2 dietBEHAVIORAL

Participants will be instructed to consume 500-600 kcal/d on fast days and eat ad libitum on feast days.

the 5:2 diet

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men or women aged 18-75 years;
  • Prediabetes;
  • Body mass index (BMI)of 28.0 to 45.0 kg/m2;

You may not qualify if:

  • History of HIV, hepatitis B or C (self-report) or active pulmonary tuberculosis;
  • Diagnosis of type 1 and type 2 diabetes;
  • History of malignant tumors;
  • Serious liver dysfunction or chronic kidney disease (AST or ALT \> 3 times the upper limit of normal, or eGFR\<30 ml/min/1.73 m2);
  • History of serious cardiovascular or cerebrovascular disease (angina, myocardial infarction or stroke) in the past 6 months;
  • History of severe gastrointestinal diseases or gastrointestinal surgery in the past 12 months;
  • History of Cushing's syndrome, hypothyroidism, acromegaly, hypothalamic obesity;
  • Being a smoker or having been a smoker in the 3 months prior to their screening visit;
  • Taking medications affecting weight or energy intake/energy expenditure in the last 6 months, including weight loss medications, antipsychotic drugs or other medications as determined by the study physician;
  • Currently participating in weight loss programs;
  • Women who are pregnant or plan to become pregnant;
  • Patients who cannot be followed for 24 months (due to a health situation or migration);
  • Patients who are unwilling or unable to give informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nanfang Hospital of Southern Medical University

Guangzhou, Guangdong, 510515, China

RECRUITING

MeSH Terms

Conditions

Prediabetic StateObesity

Interventions

Diet

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesOverweightOvernutritionNutrition DisordersBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Nutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Huijie Zhang, MD.PhD

    Department of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Huijie Zhang, MD.PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 28, 2023

First Posted

February 8, 2023

Study Start

April 11, 2023

Primary Completion

August 1, 2024

Study Completion

December 1, 2024

Last Updated

November 9, 2023

Record last verified: 2023-11

Locations